Ennapadam S Venkatraman

Suggest Changes
Learn More
PURPOSE In patients with non-small cell lung cancer (NSCLC), mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity to erlotinib and(More)